These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 18585948)
1. Characterization of the Engrailed mutant mice as experimental models for Parkinson's disease. Sgadò P; Viaggi C; Fantacci C; Corsini GU Parkinsonism Relat Disord; 2008; 14 Suppl 2():S103-6. PubMed ID: 18585948 [TBL] [Abstract][Full Text] [Related]
2. Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice. Sgadò P; Albéri L; Gherbassi D; Galasso SL; Ramakers GM; Alavian KN; Smidt MP; Dyck RH; Simon HH Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15242-7. PubMed ID: 17015829 [TBL] [Abstract][Full Text] [Related]
3. Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson's disease? Le Pen G; Sonnier L; Hartmann A; Bizot JC; Trovero F; Krebs MO; Prochiantz A Parkinsonism Relat Disord; 2008; 14 Suppl 2():S107-11. PubMed ID: 18585951 [TBL] [Abstract][Full Text] [Related]
4. Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons. Albéri L; Sgadò P; Simon HH Development; 2004 Jul; 131(13):3229-36. PubMed ID: 15175251 [TBL] [Abstract][Full Text] [Related]
5. Elevated P75NTR expression causes death of engrailed-deficient midbrain dopaminergic neurons by Erk1/2 suppression. Alavian KN; Sgadò P; Alberi L; Subramaniam S; Simon HH Neural Dev; 2009 Mar; 4():11. PubMed ID: 19291307 [TBL] [Abstract][Full Text] [Related]
6. Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease. Nordströma U; Beauvais G; Ghosh A; Pulikkaparambil Sasidharan BC; Lundblad M; Fuchs J; Joshi RL; Lipton JW; Roholt A; Medicetty S; Feinstein TN; Steiner JA; Escobar Galvis ML; Prochiantz A; Brundin P Neurobiol Dis; 2015 Jan; 73():70-82. PubMed ID: 25281317 [TBL] [Abstract][Full Text] [Related]
8. Identification and developmental analysis of genes expressed by dopaminergic neurons of the substantia nigra pars compacta. Thuret S; Bhatt L; O'Leary DD; Simon HH Mol Cell Neurosci; 2004 Mar; 25(3):394-405. PubMed ID: 15033168 [TBL] [Abstract][Full Text] [Related]
9. Midbrain dopaminergic neurons: control of their cell fate by the engrailed transcription factors. Simon HH; Thuret S; Alberi L Cell Tissue Res; 2004 Oct; 318(1):53-61. PubMed ID: 15340832 [TBL] [Abstract][Full Text] [Related]
10. Striatal dopaminergic neurons are lost with Parkinson's disease progression. Porritt MJ; Kingsbury AE; Hughes AJ; Howells DW Mov Disord; 2006 Dec; 21(12):2208-11. PubMed ID: 17029264 [TBL] [Abstract][Full Text] [Related]
11. Increased susceptibility to kainic acid-induced seizures in Engrailed-2 knockout mice. Tripathi PP; Sgadò P; Scali M; Viaggi C; Casarosa S; Simon HH; Vaglini F; Corsini GU; Bozzi Y Neuroscience; 2009 Mar; 159(2):842-9. PubMed ID: 19186208 [TBL] [Abstract][Full Text] [Related]
12. Engrailed genes control developmental fate of serotonergic and noradrenergic neurons in mid- and hindbrain in a gene dose-dependent manner. Simon HH; Scholz C; O'Leary DD Mol Cell Neurosci; 2005 Jan; 28(1):96-105. PubMed ID: 15607945 [TBL] [Abstract][Full Text] [Related]
14. Dopaminergic neurons intrinsic to the striatum. Huot P; Parent A J Neurochem; 2007 Jun; 101(6):1441-7. PubMed ID: 17286588 [TBL] [Abstract][Full Text] [Related]
15. 9-Methyl-beta-carboline up-regulates the appearance of differentiated dopaminergic neurones in primary mesencephalic culture. Hamann J; Wernicke C; Lehmann J; Reichmann H; Rommelspacher H; Gille G Neurochem Int; 2008; 52(4-5):688-700. PubMed ID: 17913302 [TBL] [Abstract][Full Text] [Related]
16. Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease. Dusonchet J; Bensadoun JC; Schneider BL; Aebischer P Neurobiol Dis; 2009 Jul; 35(1):32-41. PubMed ID: 19348945 [TBL] [Abstract][Full Text] [Related]
17. Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions. Gibrat C; Saint-Pierre M; Bousquet M; Lévesque D; Rouillard C; Cicchetti F J Neurochem; 2009 Jun; 109(5):1469-82. PubMed ID: 19457163 [TBL] [Abstract][Full Text] [Related]
18. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model. Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369 [TBL] [Abstract][Full Text] [Related]
20. Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: a post-mortem study in human control subjects. Lu L; Neff F; Fischer DA; Henze C; Hirsch EC; Oertel WH; Schlegel J; Hartmann A Neurobiol Dis; 2006 Aug; 23(2):409-21. PubMed ID: 16753304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]